Atlas Trials

Dose Optimization of Caffeine for HIE

Clinical trial NCT06448780 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06448780
Sponsor
University of North Carolina, Chapel Hill
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Hypoxic-Ischemic Encephalopathy
Start date
2024-07-26
Primary completion
2026-06-25
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.